76 related articles for article (PubMed ID: 18225580)
1. Decreased migration of myeloid dendritic cells through increased levels of C-reactive protein.
Frenzel H; Pries R; Brocks CP; Jabs WJ; Wittkopf N; Wollenberg B
Anticancer Res; 2007; 27(6B):4111-5. PubMed ID: 18225580
[TBL] [Abstract][Full Text] [Related]
2. Functional alteration of myeloid dendritic cells through head and neck cancer.
Brocks CP; Pries R; Frenzel H; Ernst M; Schlenke P; Wollenberg B
Anticancer Res; 2007; 27(2):817-24. PubMed ID: 17465207
[TBL] [Abstract][Full Text] [Related]
3. Effect of head and neck cancer supernatant and CpG-oligonucleotides on migration and IFN-alpha production of plasmacytoid dendritic cells.
Thiel A; Pries R; Jeske S; Trenkle T; Wollenberg B
Anticancer Res; 2009 Aug; 29(8):3019-25. PubMed ID: 19661310
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor interference in myeloid dendritic cells through head and neck cancer.
Frenzel H; Hoffmann B; Brocks C; Schlenke P; Pries R; Wollenberg B
Anticancer Res; 2006; 26(6B):4409-13. PubMed ID: 17201162
[TBL] [Abstract][Full Text] [Related]
5. Isolation of human myeloid dendritic cells from tumor tissue and peripheral blood.
Brocks C; Graefe H; Frenzel H; Pries R; Wollenberg B
In Vivo; 2006; 20(2):239-42. PubMed ID: 16634524
[TBL] [Abstract][Full Text] [Related]
6. Secretion of tumor-promoting and immune suppressive cytokines by cell lines of head and neck squamous cell carcinoma.
Pries R; Thiel A; Brocks C; Wollenberg B
In Vivo; 2006; 20(1):45-8. PubMed ID: 16433027
[TBL] [Abstract][Full Text] [Related]
7. Head and neck cancer triggers increased IL-6 production of CD34+ stem cells from human cord blood.
Nitsch SM; Pries R; Wollenberg B
In Vivo; 2007; 21(3):493-8. PubMed ID: 17591359
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein (CRP) induces chemokine secretion via CD11b/ICAM-1 interaction in human adherent monocytes.
Montecucco F; Steffens S; Burger F; Pelli G; Monaco C; Mach F
J Leukoc Biol; 2008 Oct; 84(4):1109-19. PubMed ID: 18591415
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolic acid impedes the antigen presenting and lymph node homing capacities of human blood myeloid dendritic cells.
Cicinnati VR; Hou J; Lindemann M; Horn PA; Sotiropoulos GC; Paul A; Gerken G; Beckebaum S
Transplantation; 2009 Aug; 88(4):504-13. PubMed ID: 19696633
[TBL] [Abstract][Full Text] [Related]
10. Increased levels of immune inhibitory CD34+ progenitor cells in the peripheral blood of patients with node positive head and neck squamous cell carcinomas and the ability of these CD34+ cells to differentiate into immune stimulatory dendritic cells.
Lathers DM; Achille N; Kolesiak K; Hulett K; Sparano A; Petruzzelli GJ; Young MR
Otolaryngol Head Neck Surg; 2001 Sep; 125(3):205-12. PubMed ID: 11555755
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of NK cell function against head and neck cancer in response to ss-isRNA requires TLR7.
Pries R; Wulff S; Kesselring R; Börngen K; Xie L; Wollenberg B
Int J Oncol; 2008 Nov; 33(5):993-1000. PubMed ID: 18949362
[TBL] [Abstract][Full Text] [Related]
12. [Clinical observation and expression of C-reactive protein by LPS-induced A549 cells in patients with chronic obstructive pulmonary disease].
Wu SJ; Zhao SP
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Apr; 30(2):207-10. PubMed ID: 15898436
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cells and HNSCC: a potential treatment option? (Review).
Dunn G; Oliver KM; Loke D; Stafford ND; Greenman J
Oncol Rep; 2005 Jan; 13(1):3-10. PubMed ID: 15583794
[TBL] [Abstract][Full Text] [Related]
14. Galectins as modulators of tumor progression in head and neck squamous cell carcinomas.
Saussez S; Camby I; Toubeau G; Kiss R
Head Neck; 2007 Sep; 29(9):874-84. PubMed ID: 17315170
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of phagocytic and chemokinetic activities of rainbow trout head kidney cells by C-reactive protein.
Kodama H; Arimitsu H; Mukamoto M; Sugimoto C
Am J Vet Res; 1999 Feb; 60(2):240-4. PubMed ID: 10048559
[TBL] [Abstract][Full Text] [Related]
16. Hyperthermia and irradiation of head and neck squamous cancer cells causes migratory profile changes of tumour infiltrating lymphocytes.
Schmidtner J; Distel LV; Ott OJ; Nkenke E; Sprung CN; Fietkau R; Lubgan D
Int J Hyperthermia; 2009 Aug; 25(5):347-54. PubMed ID: 19479600
[TBL] [Abstract][Full Text] [Related]
17. Decreased levels of circulating regulatory NK cells in patients with head and neck cancer throughout all tumor stages.
Wulff S; Pries R; Börngen K; Trenkle T; Wollenberg B
Anticancer Res; 2009 Aug; 29(8):3053-7. PubMed ID: 19661315
[TBL] [Abstract][Full Text] [Related]
18. Recruitment of myeloid and plasmacytoid dendritic cells in cervical mucosa during Chlamydia trachomatis infection.
Agrawal T; Vats V; Wallace PK; Singh A; Salhan S; Mittal A
Clin Microbiol Infect; 2009 Jan; 15(1):50-9. PubMed ID: 19046168
[TBL] [Abstract][Full Text] [Related]
19. Increase in gene dosage is a mechanism of HIF-1alpha constitutive expression in head and neck squamous cell carcinomas.
Secades P; Rodrigo JP; Hermsen M; Alvarez C; Suarez C; Chiara MD
Genes Chromosomes Cancer; 2009 May; 48(5):441-54. PubMed ID: 19235921
[TBL] [Abstract][Full Text] [Related]
20. Regulatory T cells: what role do they play in antitumor immunity in patients with head and neck cancer?
Alhamarneh O; Amarnath SM; Stafford ND; Greenman J
Head Neck; 2008 Feb; 30(2):251-61. PubMed ID: 18172882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
